Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine SR vs Divalproex Sodium ER for Anxiety in Bipolar Disorder
NCT00579280Phase 4Completed
- Sponsor
- University of South Florida
- Start
- Jul 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of quetiapine in bipolar disorder (BD), panic disorder and generalized anxiety disorder (GAD) (3 arms), sponsored by University of South Florida. Primary endpoint: Clinical Global Impression-21 Anxiety at 8 weeks. Started Jul 2007; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)panic disordergeneralized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00579280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00579280.